Medicana Health Group, a forefront multidisciplinary healthcare provider, has unveiled its strategic move to extend its esteemed services to the UK, catering to the increasing appetite for premium healthcare services.
In the wake of the COVID-19 pandemic, there’s been a noticeable shift towards private healthcare solutions, driven by individuals seeking timely and personalised medical care. Medicana Health Group is at the forefront of addressing this demand with its patient-first philosophy, focusing on “active listening and personalised attention at every stage of the patient’s journey,” from the initial assessment to the follow-up care. This bespoke approach, which has been successful in Türkiye, is now poised to redefine the landscape of private healthcare in the UK.
Venturing into the UK’s £282 Billion Healthcare Arena
Following the pandemic, the UK’s private healthcare sector witnessed a revival in 2021 and 2022, partly due to an increase in self-funding patients. An unprecedented number of individuals are now opting for private treatment, eager to avoid the NHS’s extended waiting periods and access the independent sector’s superior quality and expertise. The
Akeso report estimates the UK’s total healthcare spending in 2022 at £282 billion, with around 80% from public sources and 20% from private contributions.
Capitalising on this upward trend, Medicana plans to apply its vast expertise and broad spectrum of care services to penetrate the burgeoning private healthcare market in the UK. Introducing its validated care model, encompassing everything from cutting-edge diagnostics to specialised treatments, Medicana is poised to fulfil the escalating demand for premier private healthcare. The group’s dedication to excellence, coupled with its innovative patient care approach, makes Medicana an apt solution for the UK’s healthcare requirements.
Serving a Global Patient Demographic
Annually, Medicana Health Group extends its exemplary healthcare services to over 5.5 million patients across the globe, including at its 16 hospitals that boast an impressive bed capacity. This vast experience in delivering top-tier medical care is indicative of Medicana’s ability to cater to a wide array of healthcare needs on an international scale. The group’s entry into the UK is expected to herald a new era in empathetic, effective, and tailored healthcare services, furthering their global mission to improve patient outcomes and healthcare standards.
With over three decades of medical excellence, Medicana offers advanced services across numerous specialties, from Oncology and Organ Transplantation to IVF and Obesity Surgery. Beyond healthcare, Medicana has also ventured into education, offering a comprehensive range of academic programmes from preschool to higher education.
